Share of the population living with HIV receiving antiretroviral therapy in Algeria
Algeria: Share of the population living with HIV receiving antiretroviral therapy was 68.3% in 2024. ◆ Volatile
Share of the population living with HIV receiving antiretroviral therapy in Algeria, 1990–2024
Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.
Analysis
The most recent figure for share of the population living with hiv receiving antiretroviral therapy in Algeria is 68.3%, measured in 2024.
The figure is down 3.6% on the previous year and up 59.0% over ten years.
Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Algeria peaked at 73.9% in 2021 and was at its lowest, 0.0%, in 1990.
That places Algeria 85th out of 149 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 1.3% | 0.0% | 7.2% | 10 |
| 2000s | 10.3% | 6.1% | 15.8% | 10 |
| 2010s | 46.6% | 20.9% | 71.9% | 10 |
| 2020s | 70.9% | 68.3% | 73.9% | 5 |
Countries ranked near Algeria
More reference data data for Algeria
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 5.36 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 4.41 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.2569 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.2959 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 5.36 (2050)
- Summer temperature anomalies 1.58 °C (2026)
- Temperature anomalies by month 1.65 °C (2026)
- Spring temperature anomalies -0.093 °C (2026)
- Emission Totals - Emissions (CO2eq) from N2O (AR5) - Burning - Crop re 16.31 (2050)
- Emission Totals - Direct emissions (N2O) - Crop Residues 1.31 (2050)
Frequently asked questions
- What is share of the population living with hiv receiving antiretroviral therapy in Algeria?
- Share of the population living with hiv receiving antiretroviral therapy in Algeria was 68.3% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
- What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Algeria?
- The highest recorded value was 73.9% in 2021.
- What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Algeria?
- The lowest recorded value was 0.0% in 1990.
- How does Algeria rank for share of the population living with hiv receiving antiretroviral therapy?
- Algeria ranks 85th out of 149 countries with data for 2024.
- Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Algeria?
- Over the last ten years it is up 59.0%. The long-run trend across the full record is volatile.
- Where does this Algeria data come from?
- The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.